Neuronetics
Tracked across 4 events · 25 articles · First seen Apr 13, 2026 · Last active Jul 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Neuronetics, as the maker of NeuroStar Advanced Therapy, benefits from the expanded access to its treatment due to the policy update by UnitedHealth Group — Optum/United Healthcare/United Behavioral Health.
Apr 13, 2026 · 6 articles
Tech
Impact: Neuronetics is the primary company involved, presenting new real-world data on its NeuroStar Advanced Therapy at the CTMSS Annual Meeting, reinforcing its leadership in TMS research and potentially boosting its market position.
Jun 02, 2026 · 7 articles
Business
Impact: Neuronetics appointed Robert Greenberg as Senior Vice President Sales, which is expected to strengthen its commercial strategy and sales organizations. The company also granted him restricted stock units as an inducement.
Jun 02, 2026 · 6 articles
Business
Impact: Neuronetics announced and operates the new Center of Excellence, reinforcing its leadership in interventional mental health and expanding its clinic network.
Jul 28, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Neuronetics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard